Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.40+0.01 (+0.16%)
Close on Nov 18, 2026Market cap $242.26MP/E –Yield –
Lifecore Biomedical operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Lifecore Biomedical's operating income for the twelve months ending May 25, 2025 was -$17.25M. For fiscal 2025 it was -$17.25M. The highest annual figure on record is $24.87M in fiscal 2013.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 25, 2025 | -$17.25M | – |
| FY2024 | May 26, 2024 | -$8.84M | – |
| FY2023 | May 28, 2023 | -$21.80M | – |
| FY2022 | May 29, 2022 | -$11.79M | – |
| FY2021 | May 30, 2021 | -$8.82M | – |
| FY2020 | May 31, 2020 | -$25.88M | -572.6% |
| FY2019 | May 26, 2019 | $5.48M | -59.7% |
| FY2018 | May 27, 2018 | $13.59M | -7.4% |
| FY2017 | May 28, 2017 | $14.67M | – |
| FY2016 | May 29, 2016 | -$20.63M | -211.7% |
| FY2015 | May 31, 2015 | $18.46M | -8.6% |
| FY2014 | May 25, 2014 | $20.19M | -18.8% |
| FY2013 | May 26, 2013 | $24.87M | +70.6% |
| FY2012 | May 27, 2012 | $14.58M | +81.5% |
| FY2011 | May 29, 2011 | $8.03M | +0.6% |
| FY2010 | May 30, 2010 | $7.98M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | May 25, 2025 | $5.33M | +147.9% |
| Q3 FY2025CQ1 2025 | Feb 23, 2025 | -$9.03M | – |
| Q2 FY2025CQ4 2024 | Nov 24, 2024 | -$1.96M | – |
| Q1 FY2025CQ3 2024 | Aug 25, 2024 | -$11.58M | – |
| Q4 FY2024CQ2 2024 | May 26, 2024 | $2.15M | – |
| Q3 FY2024CQ1 2024 | Feb 25, 2024 | -$895.00K | – |
| Q2 FY2024CQ4 2023 | Nov 26, 2023 | -$1.48M | – |
| Q1 FY2024CQ3 2023 | Aug 27, 2023 | -$8.61M | – |
| Q4 FY2023CQ2 2023 | May 28, 2023 | -$6.64M | – |
| Q3 FY2023CQ1 2023 | Feb 26, 2023 | -$6.53M | – |
| Q2 FY2023CQ4 2022 | Nov 27, 2022 | -$5.35M | -245.0% |
| Q1 FY2023CQ3 2022 | Aug 28, 2022 | -$3.27M | – |
| Q4 FY2022CQ2 2022 | May 29, 2022 | -$2.51M | – |
| Q3 FY2022CQ1 2022 | Feb 27, 2022 | -$9.64M | -13302.7% |
| Q2 FY2022CQ4 2021 | Nov 28, 2021 | $3.69M | +168.6% |
| Q1 FY2022CQ3 2021 | Aug 29, 2021 | -$4.22M | – |
| Q4 FY2021CQ2 2021 | May 30, 2021 | -$6.63M | – |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $73.00K | – |
| Q2 FY2021CQ4 2020 | Nov 29, 2020 | $1.37M | – |
| Q1 FY2021CQ3 2020 | Aug 30, 2020 | -$10.60M | – |
| Q4 FY2020CQ2 2020 | May 31, 2020 | -$449.00K | -118.1% |
| Q3 FY2020CQ1 2020 | Feb 23, 2020 | -$15.01M | -563.0% |
| Q2 FY2020CQ4 2019 | Nov 24, 2019 | -$6.04M | -60460.0% |
| Q1 FY2020CQ3 2019 | Aug 25, 2019 | -$4.38M | – |
| Q4 FY2019CQ2 2019 | May 26, 2019 | $2.48M | -69.3% |
| Q3 FY2019CQ1 2019 | Feb 24, 2019 | $3.24M | -7.0% |
| Q2 FY2019CQ4 2018 | Nov 25, 2018 | $10.00K | – |
| Q1 FY2019CQ3 2018 | Aug 26, 2018 | -$257.00K | -109.4% |
| Q4 FY2018CQ2 2018 | May 27, 2018 | $8.07M | +402.9% |
| Q3 FY2018CQ1 2018 | Feb 25, 2018 | $3.49M | -19.5% |
| Q2 FY2018CQ4 2017 | Nov 26, 2017 | -$695.00K | -121.3% |
| Q1 FY2018CQ3 2017 | Aug 27, 2017 | $2.73M | -50.2% |
| Q4 FY2017CQ2 2017 | May 28, 2017 | $1.61M | -74.3% |
| Q3 FY2017CQ1 2017 | Feb 26, 2017 | $4.33M | – |
| Q2 FY2017CQ4 2016 | Nov 27, 2016 | $3.26M | – |
| Q1 FY2017CQ3 2016 | Aug 28, 2016 | $5.47M | – |
| Q4 FY2016CQ2 2016 | May 29, 2016 | $6.25M | – |
| Q3 FY2016CQ1 2016 | Feb 28, 2016 | -$33.62M | – |
See a number that looks wrong?